Gelsolin inhibits malignant phenotype of glioblastoma and is regulated by miR‐654‐5p and miR‐450b‐5p

We have previously shown that gelsolin (GSN) levels are significantly lower in the blood of patients with glioblastoma (GBM) than in healthy controls. Here, we analyzed the function of GSN in GBM and examined its clinical significance. Furthermore, microRNAs involved in GSN expression were also iden...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jiakang, Furuta, Takuya, Sabit, Hemragul, Tamai, Sho, Jiapaer, Shabierjiang, Dong, Yu, Kinoshita, Masashi, Uchida, Yasuo, Ohtsuki, Sumio, Terasaki, Tetsuya, Zhao, Shiguang, Nakada, Mitsutoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385387/
https://www.ncbi.nlm.nih.gov/pubmed/32324311
http://dx.doi.org/10.1111/cas.14429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385387/
https://www.ncbi.nlm.nih.gov/pubmed/32324311
http://dx.doi.org/10.1111/cas.14429

Ejemplares similares